1. Home
  2. MIRA vs JEWL Comparison

MIRA vs JEWL Comparison

Compare MIRA & JEWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIRA
  • JEWL
  • Stock Information
  • Founded
  • MIRA 2020
  • JEWL 2018
  • Country
  • MIRA United States
  • JEWL United States
  • Employees
  • MIRA N/A
  • JEWL N/A
  • Industry
  • MIRA Biotechnology: Pharmaceutical Preparations
  • JEWL Consumer Specialties
  • Sector
  • MIRA Health Care
  • JEWL Consumer Discretionary
  • Exchange
  • MIRA Nasdaq
  • JEWL Nasdaq
  • Market Cap
  • MIRA 10.9M
  • JEWL 7.2M
  • IPO Year
  • MIRA 2023
  • JEWL 2022
  • Fundamental
  • Price
  • MIRA $0.69
  • JEWL $0.31
  • Analyst Decision
  • MIRA
  • JEWL
  • Analyst Count
  • MIRA 0
  • JEWL 0
  • Target Price
  • MIRA N/A
  • JEWL N/A
  • AVG Volume (30 Days)
  • MIRA 1.7M
  • JEWL 547.8K
  • Earning Date
  • MIRA 09-13-2024
  • JEWL 08-27-2024
  • Dividend Yield
  • MIRA N/A
  • JEWL N/A
  • EPS Growth
  • MIRA N/A
  • JEWL N/A
  • EPS
  • MIRA N/A
  • JEWL N/A
  • Revenue
  • MIRA N/A
  • JEWL $1,818,042.00
  • Revenue This Year
  • MIRA N/A
  • JEWL N/A
  • Revenue Next Year
  • MIRA N/A
  • JEWL N/A
  • P/E Ratio
  • MIRA N/A
  • JEWL N/A
  • Revenue Growth
  • MIRA N/A
  • JEWL 65.04
  • 52 Week Low
  • MIRA $0.51
  • JEWL $0.17
  • 52 Week High
  • MIRA $6.95
  • JEWL $2.01
  • Technical
  • Relative Strength Index (RSI)
  • MIRA 49.12
  • JEWL 46.89
  • Support Level
  • MIRA $0.51
  • JEWL $0.30
  • Resistance Level
  • MIRA $0.89
  • JEWL $0.35
  • Average True Range (ATR)
  • MIRA 0.10
  • JEWL 0.08
  • MACD
  • MIRA 0.02
  • JEWL -0.01
  • Stochastic Oscillator
  • MIRA 38.21
  • JEWL 24.52

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

About JEWL Adamas One Corp.

Adamas One Corp is a high-tech diamond company that uses its proprietary technology to produce high-quality, single-crystal diamonds and diamond materials through a CVD process, which it refers to as Diamond Technology. It operates as a Lab-Grown Diamond manufacturer that produces single-crystal diamonds for gemstone and industrial applications. The company produces chemical vapor deposition (CVD) gem-sized Lab-Grown Diamond crystals using processes pioneered by Apollo Diamond. The company's controlled manufacturing processes enable it to produce High-Quality, High Purity, High Volume, single-crystal colorless, near-colorless, and fancy-colored diamonds to suit a variety of industrial and gemstone applications.

Share on Social Networks: